Literature DB >> 24747666

Targeting of DNA Damage Signaling Pathway Induced Senescence and Reduced Migration of Cancer cells.

Ran Gao1, Rumani Singh1, Zeenia Kaul2, Sunil C Kaul1, Renu Wadhwa3.   

Abstract

The heat shock 70 family protein, mortalin, has pancytoplasmic distribution pattern in normal and perinuclear in cancer human cells. Cancer cells when induced to senesce by either chemicals or stress showed shift in mortalin staining pattern from perinuclear to pancytoplasmic type. Using such shift in mortalin staining as a reporter, we screened human shRNA library and identified nine senescence-inducing siRNA candidates. An independent Comparative Genomic Hybridization analysis of 35 breast cancer cell lines revealed that five (NBS1, BRCA1, TIN2, MRE11A, and KPNA2) of the nine genes located on chromosome regions identified as the gain of locus in more than 80% cell lines. By gene-specific PCR, these five genes were found to be frequently amplified in cancer cell lines. Bioinformatics revealed that the identified targets were connected to MRN (MRE11-RAD50-NBS1) complex, the DNA damage-sensing complex. We demonstrate that the identified shRNAs triggered DNA damage response and induced the expression of tumor suppressor protein p16(INK4A) causing growth arrest of cancer cells. Furthermore, cells showed decreased migration, mediated by decrease in matrix metalloproteases. Taken together, we demonstrate that the MRN complex is a potential target of cancer cell proliferation and migration, and staining pattern of mortalin could serve as an assay to identify senescence-inducing/anticancer reagents.
© The Author 2014. Published by Oxford University Press on behalf of the Gerontological Society of America. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Bioinformatics; Cancer; DNA damage pathway; Growth arrest.; Induced senescence; Mortalin staining pattern; p16INK4A; shRNA screening

Mesh:

Substances:

Year:  2014        PMID: 24747666     DOI: 10.1093/gerona/glu019

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  8 in total

1.  Excess centrosomes induce p53-dependent senescence without DNA damage in endothelial cells.

Authors:  Zhixian Yu; Dana L Ruter; Erich J Kushner; Victoria L Bautch
Journal:  FASEB J       Date:  2017-06-16       Impact factor: 5.191

2.  Human MutT homologue 1 mRNA overexpression correlates to poor response of multiple myeloma.

Authors:  Huixing Zhou; Yuan Jian; Yun Leng; Nian Liu; Ying Tian; Guorong Wang; Wen Gao; Guangzhong Yang; Wenming Chen
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

Review 3.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

4.  Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.

Authors:  Mariko Tsukagoshi; Kenichiro Araki; Takehiko Yokobori; Bolag Altan; Hideki Suzuki; Norio Kubo; Akira Watanabe; Norihiro Ishii; Yasuo Hosouchi; Masahiko Nishiyama; Ken Shirabe; Hiroyuki Kuwano
Journal:  Oncotarget       Date:  2017-06-27

5.  MicroRNA regulation of the MRN complex impacts DNA damage, cellular senescence, and angiogenic signaling.

Authors:  Cristina Espinosa-Diez; RaeAnna Wilson; Namita Chatterjee; Clayton Hudson; Rebecca Ruhl; Christina Hipfinger; Erin Helms; Omar F Khan; Daniel G Anderson; Sudarshan Anand
Journal:  Cell Death Dis       Date:  2018-05-24       Impact factor: 8.469

6.  Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers.

Authors:  Jayarani F Putri; Priyanshu Bhargava; Jaspreet Kaur Dhanjal; Tomoko Yaguchi; Durai Sundar; Sunil C Kaul; Renu Wadhwa
Journal:  J Exp Clin Cancer Res       Date:  2019-12-19

Review 7.  MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment.

Authors:  Lei Bian; Yiling Meng; Meichao Zhang; Dong Li
Journal:  Mol Cancer       Date:  2019-11-26       Impact factor: 27.401

8.  CARF enrichment promotes epithelial-mesenchymal transition via Wnt/β-catenin signaling: its clinical relevance and potential as a therapeutic target.

Authors:  Rajkumar S Kalra; Anupama Chaudhary; A-Rum Yoon; Priyanshu Bhargava; Amr Omar; Sukant Garg; Chae-Ok Yun; Sunil C Kaul; Renu Wadhwa
Journal:  Oncogenesis       Date:  2018-05-11       Impact factor: 7.485

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.